SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001114220-17-000046
Filing Date
2017-11-07
Accepted
2017-11-07 08:50:09
Documents
58
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kerx-9302017x10q.htm 10-Q 725959
2 EXHIBIT 10.1 kerx-9302017x10qex101.htm EX-10.1 269990
3 EXHIBIT 10.2 kerx-9302017x10qex102.htm EX-10.2 35476
4 EXHIBIT 31.1 kerx-9302017x10qex311.htm EX-31.1 13175
5 EXHIBIT 31.2 kerx-9302017x10qex312.htm EX-31.2 13086
6 EXHIBIT 32.1 kerx-9302017x10qex321.htm EX-32.1 6192
7 EXHIBIT 32.2 kerx-9302017x10qex322.htm EX-32.2 6240
  Complete submission text file 0001114220-17-000046.txt   3934993

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kerx-20170930.xml EX-101.INS 638885
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kerx-20170930.xsd EX-101.SCH 29779
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kerx-20170930_cal.xml EX-101.CAL 57722
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kerx-20170930_def.xml EX-101.DEF 125008
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kerx-20170930_lab.xml EX-101.LAB 413012
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kerx-20170930_pre.xml EX-101.PRE 238047
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 171181242
SIC: 2834 Pharmaceutical Preparations